Natco Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve considering Audited Financial ....
NATCOPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Natco Pharma Ltd has informed exchanges about a board meeting scheduled for May 29, 2026. The meeting will consider and approve the Audited Financial Results for the quarter and year ended March 31, 2026. The company has also announced the closure of the trading window under SEBI Insider Trading Regulations, effective from May 19, 2026, until 48 hours after the results are declared. This is a routine quarterly and annual results announcement as required under listing regulations. The actual financial figures and any material developments will be known only after the board meeting.
This is a standard disclosure and does not itself indicate any positive or negative development. The actual impact on the stock will depend on the financial results to be declared. Investors should note the trading window closure and avoid trading in company securities during the restricted period.